Anti-pneumococcal Vaccine Strategy in Patients With Chronic Lymphocytic Leukemia

Abroad (travel likely)RecruitingPHASE2

Conditions

Chronic Lymphocytic Leukemia · Small Lymphocytic Lymphoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
Contact: Study coordinator (Seema A. Bhat, MD) · Seema.bhat@osumc.edu
Contact: Principal Investigator (Seema A. Bhat, MD)

Study leads

Seema A Bhat, MD
Principal Investigator
Ohio State University Comprehensive Cancer Center

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Testing the Effectiveness of the Anti-cancer Drug, Mirdametinib, in Treating Relapsed, Refractory Chronic Lymphocytic Leukemia

Recurrent Chronic Lymphocytic Leukemia · Recurrent Small Lymphocytic Lymphoma · Refractory Chronic Lymphocytic Leukemia

Abroad (travel likely)RecruitingPHASE2

Duarte, United States · Irvine, United States

DZD8586 in Patients With Relapsed or Refractory CLL/SLL (TAI-SHAN8)

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Abroad (travel likely)RecruitingPHASE2

Hefei, China · Beijing, China

Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies

Acute Leukemia · Acute Lymphoblastic Leukemia · Acute Myeloid Leukemia

Abroad (travel likely)RecruitingPHASE2

Seattle, United States

A Study of Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Chronic Lymphocytic Leukemia (CLL) · Small Lymphocytic Lymphoma (SLL)

Abroad (travel likely)RecruitingPHASE2

Concord, Australia · Kogarah, Australia